220 related articles for article (PubMed ID: 18282643)
1. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
[TBL] [Abstract][Full Text] [Related]
2. Cyclin A activity predicts clinical outcome in oral precancer and cancer.
Thomson PJ; Goodson ML; Booth C; Cragg N; Hamadah O
Int J Oral Maxillofac Surg; 2006 Nov; 35(11):1041-6. PubMed ID: 16962288
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study.
Hamadah O; Thomson PJ
Lasers Surg Med; 2009 Jan; 41(1):17-25. PubMed ID: 19143013
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions.
Hamadah O; Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2010 Oct; 48(7):503-6. PubMed ID: 19800717
[TBL] [Abstract][Full Text] [Related]
5. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management.
Thomson PJ; Wylie J
Int J Oral Maxillofac Surg; 2002 Apr; 31(2):145-53. PubMed ID: 12102411
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
7. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
[TBL] [Abstract][Full Text] [Related]
9. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity.
Liu SC; Sauter ER; Clapper ML; Feldman RS; Levin L; Chen SY; Yen TJ; Ross E; Engstrom PF; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):597-603. PubMed ID: 9681528
[TBL] [Abstract][Full Text] [Related]
10. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle dysregulation influences survival in high risk breast cancer patients.
Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours.
Hara A; Saegusa M; Ichinoe M; Okayasu I
J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cyclin D1, p27, and p63 in oral leukoplakia.
Kövesi G; Szende B
J Oral Pathol Med; 2006 May; 35(5):274-7. PubMed ID: 16630290
[TBL] [Abstract][Full Text] [Related]
15. Cancerisation within the oral cavity: the use of 'field mapping biopsies' in clinical management.
Thomson PJ; Hamadah O
Oral Oncol; 2007 Jan; 43(1):20-6. PubMed ID: 16757199
[TBL] [Abstract][Full Text] [Related]
16. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F
J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605
[TBL] [Abstract][Full Text] [Related]
17. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Obermann EC; Went P; Pehrs AC; Tzankov A; Wild PJ; Pileri S; Hofstaedter F; Dirnhofer S
Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239
[TBL] [Abstract][Full Text] [Related]
18. The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions.
Vladimirov BS; Schiodt M
Int J Oral Maxillofac Surg; 2009 Nov; 38(11):1188-93. PubMed ID: 19640683
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
20. Endomitosis and polyploidization of myocardial cells in the periphery of human acute myocardial infarction.
Meckert PC; Rivello HG; Vigliano C; González P; Favaloro R; Laguens R
Cardiovasc Res; 2005 Jul; 67(1):116-23. PubMed ID: 15949475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]